Los Angeles Cancer Network

What Los Angeles Cancer Network does

Los Angeles Cancer Network (LACN), rebranding to Oncura Health as of February 2026, is a community-based, multi-specialty oncology group operating 25+ outpatient clinics across Los Angeles, Riverside, and Orange counties in Southern California. Founded in 1975, the practice employs 40+ board-certified hematologists and oncologists, 25+ advanced practice practitioners, and a four-person pharmacy team led by a Chief Pharmacy Officer and Director of Pharmaceutical Care. LACN delivers comprehensive cancer care including chemotherapy, immunotherapy, intensity-modulated radiation therapy (IMRT), and infusion therapy, and maintains inpatient affiliations with major Southern California systems including Cedars-Sinai, Providence Health, Adventist Health, and Dignity Health. The practice operates an in-office dispensary that coordinates medication dispensing and financial assistance for patients.

LACN's technology infrastructure centers on the Navigating Care Patient Portal—providing 24/7 access to health records, lab results, appointment scheduling, and secure messaging—alongside telemedicine services delivered through UPDOX Video Chat and Zoom. The practice is a partner of OneOncology, the national oncology practice management platform founded in 2018, which supplies capital, centralized data analytics, and access to the OneOncology Research Network (OneR) for multi-center clinical trials. In June 2025, LACN announced a strategic partnership with the START Center for Cancer Research to establish the START Los Angeles site, the 15th in START's global early-phase oncology trial network, with early-phase trials launching in early 2026. LACN also participates as a site in the BriaCell Phase 3 trial, which expanded to 79 sites.

The business operates on a professional-services revenue model with three streams: outpatient oncology care billed through insurance reimbursement (Medicare, Medicaid, commercial payers); clinical research revenue from pharmaceutical sponsors, cooperative groups (SWOG), OneR, and the upcoming START partnership; and inpatient professional services through hospital affiliations. Patient acquisition is driven by physician referrals, hospital partnerships, and clinical trial access rather than direct-to-consumer marketing. Pricing is not publicly disclosed and revenue figures are not available. The February 2026 rebranding to Oncura Health, accompanied by a new Tarzana clinic, signals continued geographic and brand expansion across Southern California.

Name

Los Angeles Cancer Network

Legal name

Los Angeles Cancer Network

Website

https://lacancernetwork.com

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

101–250 employees

Short description

Los Angeles Cancer Network, rebranding to Oncura Health, is a community-based multi-specialty oncology group operating 25+ outpatient clinics across Los Angeles, Riverside, and Orange counties, delivering chemotherapy, immunotherapy, radiation, and infusion therapy to cancer and hematology patients via 40+ board-certified physicians and major hospital affiliations.

Ownership category

akta.pro rank

Product category

Oncology and Hematology Services

NAICS

Offices of Physicians (62111), Ambulatory Health Care Services (621)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD), Gynecologic Oncology & Women’s Cancer Centers (HLAFAJAK)

Keywords

• Community oncology care
• Outpatient cancer treatment
• Chemotherapy infusion services
• Hematology specialty care
• Radiation therapy IMRT

Headquarters

HQ city

Los Angeles

HQ country

United States

HQ region

North America

Offices23 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Outpatient Oncology Care: Revenue generated from providing outpatient cancer treatment and hematology services across 25+ clinic locations. Services include chemotherapy, immunotherapy, infusion therapy, and radiation therapy (IMRT). Billed through insurance reimbursement including Medicare, Medicaid, and commercial payers.
2. Clinical Research: Revenue from conducting clinical trials as a principal investigation site for pharmaceutical sponsors, cooperative groups (SWOG), and the OneOncology Research Network. Early-phase trials with START partnership beginning 2026.
3. Hospital Affiliation Services: Inpatient consultation and treatment services provided through affiliated hospitals across Southern California, including Cedars-Sinai, Providence hospitals, Adventist Health, and Dignity Health facilities.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Los Angeles Cancer Network provides community-based outpatient oncology and hematology care across 25+ clinics in Southern California. Core services include chemotherapy, immunotherapy, intensity-modulated radiation therapy (IMRT), and infusion therapy, complemented by in-office pharmacy, clinical trials through the OneOncology Research Network and START Center for Cancer Research, and a Navigating Care patient portal with telemedicine options. The practice serves individual cancer and blood disorder patients via physician referrals, direct appointments, and hospital affiliations with health systems including Cedars-Sinai, Providence, Adventist Health, and Dignity Health.

Product overview

Los Angeles Cancer Network (rebranding to Oncura Health) operates as a community-based, multi-specialty oncology group providing comprehensive cancer and blood disorder treatment through a network of 25+ outpatient clinics across Los Angeles, Riverside, and Orange counties in Southern California. The organization offers a unified care platform centered on chemotherapy, immunotherapy, IMRT radiation therapy, and infusion therapy services, supplemented by a patient-facing Navigating Care digital portal for health record access and care coordination. The network provides telemedicine appointment options via UPDOX Video Chat and Zoom Conferencing, and has expanded into early-phase clinical trial access through partnerships with START Center for Cancer Research and the OneOncology Research Network.

Differentiator

Problem solved

Functional benefit

Products and services

• Chemotherapy Systemic cancer treatment using potent drugs to destroy cancer cells or slow their growth; delivered in outpatient clinic infusion rooms.
• Immunotherapy Cancer treatment that uses the body's immune system to fight cancer cells; offered as part of the comprehensive oncology service portfolio.
• IMRT (Intensity-Modulated Radiation Therapy) Advanced radiation therapy technique that modulates radiation beams to precisely target cancer cells while minimizing damage to surrounding healthy tissue.
• Infusion Therapy Administration of medications, including chemotherapy and targeted therapies, through intravenous delivery in an outpatient clinical setting.
• Navigating Care Patient Portal Secure digital portal providing 24/7 online access for patients to view health records, lab results, appointment times, communicate with care teams, and access educational content about treatments.
• Telemedicine Appointments Remote healthcare consultations conducted via video chat platforms (UPDOX Video Chat and Zoom Conferencing) to provide continued patient care outside of in-person visits.
• Clinical Trials / Early-Phase Oncology Trials Access to early-phase clinical oncology trials through partnership with START Center for Cancer Research and the OneOncology Research Network (OneR), enabling patient access to innovative therapies.
• Hematology Services Diagnosis and treatment of benign and malignant blood disorders, including leukemia, lymphoma, myeloma, anemia, and coagulation disorders, delivered by board-certified hematologists across the network.
• Gynecologic Oncology Services Specialized oncology care for gynecologic cancers delivered by gynecologic oncologists across the network, including surgical and medical oncology management.
• In-Office Dispensary / Prescription Services On-site pharmacy services providing medication and financial assistance coordination for patients receiving cancer treatment at the network's clinics.

Quantifiable outcome

• Serving population of 14+ million with estimated 100,000 new cancer diagnoses annually
• +1 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature4 records

Partnerships

Five partnerships are on record, tiered core.

• START Center for Cancer ResearchcoreStrategic or Co-development Partner · 23 June 2025The START Center for Cancer Research is the world's largest community-based network specializing in early-phase oncology trials. The partnership launched the START Los Angeles site, the 15th site in the START Network, embedded in one of the nation's largest community-based oncology practices. The partnership aims to expand patient and physician access to early-phase oncology trials within the communities the network serves, with early-phase clinical trials beginning in early 2026.
• START Los Angeles SitecoreStrategic or Co-development Partner · 23 June 2025New clinical trial site embedded within Los Angeles Cancer Network, launching early-phase oncology trials as the 15th site in the START Network. Partnership with OneOncology announced June 23, 2025, to launch early phase clinical trial sites serving a population of more than 14 million people with approximately 100,000 new cancer diagnoses annually.
• OneOncologycoreStrategic or Co-development PartnerFounded in 2018 for physicians, by physicians, with the vision of transforming cancer care delivery in the United States. OneOncology provides community oncology practices with capital, customized technology, and expertise. The partnership focuses on four key pillars: practice management, data analytics, research, and value-based care. Los Angeles Cancer Network is a Partner of OneOncology, benefiting from national buying power, data analytics tools, and access to the OneOncology Research Network (OneR) for clinical trial management.
• OneOncology Research Network (OneR)coreStrategic or Co-development PartnerNational site management organization that brings operational expertise and centralized services to efficiently deliver multi-center clinical research across the growing network of oncology practices. Expands patients' access to innovative therapies and provides clinical trial sponsors access to diverse patient populations treated in community centers.
• Oncura HealthcoreStrategic or Co-development PartnerFormer name of Los Angeles Cancer Network. The organization announced its rebranding to Oncura Health in February 2026, with a new clinic opening in Tarzana under the new name. This represents organizational growth and expansion of specialty cancer care services in Southern California.

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Compass Oncology: US Oncology Network-affiliated community oncology practice in Oregon and Washington; directly comparable multi-site community oncology model with research, infusion, and radiation services, though serving Pacific Northwest rather than Southern California.
• Texas Oncology: Member practice of the US Oncology Network operating 200+ sites across Texas; closely comparable in multi-specialty oncology services, clinical research partnerships, and hospital-affiliated care delivery model.
• Florida Cancer Specialists & Research Institute: Largest independent community oncology practice in the US with 100+ locations across Florida; nearly identical business model combining outpatient treatment, clinical research, and physician-owned governance, serving as a strong scale benchmark for LACN's growth trajectory.
• Tennessee Oncology: OneOncology founding partner practice operating 30+ clinics across Tennessee and adjacent states; closest direct comparable to LACN as a OneOncology affiliate with identical partnership economics, value-based care infrastructure, and multi-site community oncology model.
• The Oncology Institute: Public community oncology practice operating multi-site clinics across California and other states; directly comparable to LACN in service mix (chemo, infusion, hematology) and value-based care positioning, though larger geographic footprint and publicly traded structure differ.
• Sarah Cannon Research Institute: One of the largest community-based clinical trial networks in oncology; directly comparable to LACN's START partnership model and clinical research revenue stream, with comparable focus on expanding trial access in community settings.

Broad incumbents

• Cedars-Sinai Medical Center: Academic medical center and LACN hospital affiliate; competing academic institution with comprehensive cancer program, clinical research infrastructure, and physician referral pull that overlaps with LACN's specialty oncology catchment.
• City of Hope: Major NCI-designated academic cancer center with growing community satellite network across Southern California; overlapping with LACN's service area and competing for complex cases, clinical trials, and specialty referrals.
• US Oncology Network (McKesson): Large multi-state oncology practice network owned by McKesson; represents the established incumbent in community oncology consolidation with similar practice management, technology, and research support infrastructure to what OneOncology provides LACN.

Others

• START Center for Cancer Research: Strategic research partner operating the world's largest community-based early-phase oncology trial network; comparable in clinical trial infrastructure and community oncology research model, serving as both collaborator and parallel network operator.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/lacancernetwork
• Facebookfacebook.com/lacancernetwork
• LinkedInlinkedin.com/company/los-angeles-cancer-network

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Los Angeles Cancer Network